Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 389
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04420975 | Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma | ||
| NCT02881242 | Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer | ||
| NCT02310594 | Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy | ||
| NCT00096057 | Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer | ||
| NCT01351220 | Community Dissemination of an Evidence-based Colorectal Cancer (CRC) Screening Intervention | ||
| NCT06090903 | Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma | ||
| NCT04854044 | ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma | ||
| NCT00112983 | Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria | ||
| NCT00039273 | Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer | ||
| NCT04705025 | Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer | ||
| NCT00005996 | SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors | ||
| NCT00068510 | Vaccine Therapy in Treating Patients With Malignant Glioma | ||
| NCT01873248 | Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective | ||
| NCT00003748 | Irinotecan in Treating Patients With Esophageal or Stomach Cancer | ||
| NCT02049593 | PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT01813877 | Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma | ||
| NCT06432036 | Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial | ||
| NCT00020878 | Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers | ||
| NCT00100997 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate | ||
| NCT06543576 | External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer | ||
| NCT00098917 | Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | ||
| NCT05457959 | Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant | ||
| NCT00012142 | CCI-779 in Treating Patients With Prostate Cancer | ||
| NCT05978128 | Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants | ||
| NCT00301990 | Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | ||
| NCT04290897 | Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors | ||
| NCT07118176 | Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers | ||
| NCT01990196 | Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer | ||
| NCT06980077 | Ivonescimab for the Treatment of Thymic Cancer | ||
| NCT04185311 | Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted | ||
| NCT00022334 | Vaccine Therapy in Treating Patients With Liver Cancer | ||
| NCT04460495 | Quantifying Oxygen Utilization of Tumors Using Oxygen-Enhanced Molecular MRI | ||
| NCT00104767 | Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | ||
| NCT01051037 | Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways | ||
| NCT00003098 | Diet and Estrogen Metabolism in Postmenopausal Women | ||
| NCT03618134 | Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner | ||
| NCT02357121 | Focal Laser Ablation of Prostate Tissue | ||
| NCT04201873 | Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma | ||
| NCT03425461 | Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma | ||
| NCT00004881 | Vaccine Therapy in Treating Patients With Advanced Cancer | ||
| NCT04624256 | Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial | ||
| NCT02425228 | Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer | ||
| NCT00021008 | ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer | ||
| NCT02701153 | Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort | ||
| NCT00071968 | Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse | ||
| NCT03904251 | CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia | ||
| NCT01005472 | Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma | ||
| NCT04299620 | Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy | ||
| NCT04119024 | Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors | ||
| NCT00090896 | CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery |
